ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
112.86 EUR
+1.16 (+1.04%)
ILU gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. ILU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ILU has a decent growth rate and is not valued too expensively. With these ratings, ILU could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
ILU had positive earnings in the past year.
In the past year ILU had a positive cash flow from operations.
In multiple years ILU reported negative net income over the last 5 years.
ILU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of ILU (11.38%) is better than 94.74% of its industry peers.
With an excellent Return On Equity value of 29.53%, ILU belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ILU's Return On Invested Capital of 14.61% is amongst the best of the industry. ILU outperforms 94.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of ILU (16.39%) is better than 89.47% of its industry peers.
With an excellent Operating Margin value of 20.41%, ILU belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
ILU's Operating Margin has declined in the last couple of years.
ILU has a better Gross Margin (66.74%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILU is creating some value.
Compared to 1 year ago, ILU has about the same amount of shares outstanding.
Compared to 5 years ago, ILU has more shares outstanding
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.33 indicates that ILU is not in any danger for bankruptcy at the moment.
ILU has a Altman-Z score of 4.33. This is in the better half of the industry: ILU outperforms 78.95% of its industry peers.
The Debt to FCF ratio of ILU is 1.99, which is an excellent value as it means it would take ILU, only 1.99 years of fcf income to pay off all of its debts.
ILU's Debt to FCF ratio of 1.99 is amongst the best of the industry. ILU outperforms 94.74% of its industry peers.
ILU has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ILU has a better Debt to Equity ratio (0.42) than 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.33 |
ROIC/WACC1.47
WACC9.92%
2.3 Liquidity
ILU has a Current Ratio of 1.43. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.43, ILU perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ILU (1.12) is better than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 152.02% over the past year.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
ILU shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
Based on estimates for the next years, ILU will show a very strong growth in Earnings Per Share. The EPS will grow by 24.49% on average per year.
ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.93% yearly.
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.49%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 30.18, the valuation of ILU can be described as expensive.
ILU's Price/Earnings ratio is in line with the industry average.
ILU's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.11.
Based on the Price/Forward Earnings ratio of 25.99, the valuation of ILU can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ILU.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, ILU is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.18 | ||
| Fwd PE | 25.99 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ILU.
Based on the Price/Free Cash Flow ratio, ILU is valued a bit cheaper than 78.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.08 | ||
| EV/EBITDA | 17.89 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ILU has a very decent profitability rating, which may justify a higher PE ratio.
ILU's earnings are expected to grow with 33.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y43.68%
EPS Next 3Y33.01%
5. Dividend
5.1 Amount
ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (11/28/2025, 7:00:00 PM)
112.86
+1.16 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.96%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap17.25B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target103.69 (-8.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)6.03%
PT rev (3m)6.46%
EPS NQ rev (1m)3.76%
EPS NQ rev (3m)2.65%
EPS NY rev (1m)3.19%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0.81%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.18 | ||
| Fwd PE | 25.99 | ||
| P/S | 4.68 | ||
| P/FCF | 20.08 | ||
| P/OCF | 17.9 | ||
| P/B | 8.43 | ||
| P/tB | 19.26 | ||
| EV/EBITDA | 17.89 |
EPS(TTM)3.74
EY3.31%
EPS(NY)4.34
Fwd EY3.85%
FCF(TTM)5.62
FCFY4.98%
OCF(TTM)6.31
OCFY5.59%
SpS24.1
BVpS13.38
TBVpS5.86
PEG (NY)0.32
PEG (5Y)N/A
Graham Number33.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.33 |
F-Score7
WACC9.92%
ROIC/WACC1.47
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.49%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.85%
EBIT Next 3Y15.15%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
What is the valuation of ILLUMINA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ILLUMINA INC (ILU.DE) is 30.18 and the Price/Book (PB) ratio is 8.43.
What is the earnings growth outlook for ILLUMINA INC?
The Earnings per Share (EPS) of ILLUMINA INC (ILU.DE) is expected to grow by 93.48% in the next year.